Monogram (MGRM) Form 4 — 250K Option Grant to CTO Disclosed
Rhea-AI Filing Summary
Monogram Technologies insider option grant to CTO reported. The filing shows Kamran Shamaei, identified as Chief Technology Officer and a director/officer, was granted a stock option on 01/08/2025 to acquire 250,000 shares of common stock at an exercise price of $2.50 per share. The option becomes exercisable on 01/08/2032 and expires on 01/08/2035. The reported transaction increases direct beneficial ownership by 250,000 shares. The explanation notes the company uses the Black-Scholes model to value stock awards.
Positive
- Clear disclosure of option grant amount (250,000 shares), strike price ($2.50), grant date (01/08/2025), exercisable date (01/08/2032) and expiration (01/08/2035).
- Reporting person identified with role (Chief Technology Officer and director), aiding transparency.
Negative
- Potential dilution from 250,000 underlying shares (explicit amount disclosed) may affect outstanding share count when exercised.
- Long deferral to exercisability (exercisable beginning 2032) delays realization and makes near-term incentive alignment less direct (terms explicitly stated).
Insights
TL;DR: A standard long-dated option grant to a senior officer; disclosure is routine and informational for investors.
The Form 4 discloses a single derivative transaction: a non-qualified stock option awarded to the Chief Technology Officer for 250,000 underlying shares at a $2.50 strike, granted 01/08/2025, exercisable beginning 01/08/2032 and expiring 01/08/2035. This increases direct beneficial ownership by 250,000 shares. The filing is clear on dates, amount, and strike and includes a note that Black-Scholes is used for valuation. From a securities-disclosure perspective, the report meets Section 16 requirements and provides necessary timing and economic terms for market participants.
TL;DR: Insider compensation action disclosed; materiality is limited to compensation and dilution implications.
The report identifies the recipient as both an officer and director and documents a sizable option grant (250,000 shares). Terms are long-dated with a multi-year vest/exercise window (exercisable 2032, expiring 2035). The filing includes the company's valuation methodology for awards (Black-Scholes). This is a governance disclosure relevant to executive pay and potential future dilution but does not indicate any unusual related-party transaction or deviation from standard award practices based on the information provided.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 250,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The Company uses the Black-Scholes-Merton ("Black-Scholes") option-pricing model to determine the fair value of stock awards. The Black-Scholes option-pricing model requires the use of highly subjective and complex assumptions, including the estimated fair value and price volatility of the Company's common stock and the expected term of the option.
AI-generated analysis. How Rhea-AI works. Not financial advice.
